Performance of ANVS Annovis Bio Inc | -38.4% in 12m
Compare ANVS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Annovis Bio Inc with its related Sector/Index XBI
Performance Duell ANVS vs XBI
| TimeFrame | ANVS | XBI |
|---|---|---|
| 1 Day | 3.49% | -1.52% |
| 1 Week | 21.3% | 1.45% |
| 1 Month | -17.4% | 10.08% |
| 3 Months | -17.4% | -1.30% |
| 6 Months | 37.1% | 24.09% |
| 12 Months | -38.4% | 6.83% |
| YTD | -56.1% | 1.05% |
| Rel. Perf. 1m | -2.67 | |
| Rel. Perf. 3m | -7.85 | |
| Rel. Perf. 6m | 0.52 | |
| Rel. Perf. 12m | -5.81 |
Is Annovis Bio Inc a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Annovis Bio Inc (NYSE:ANVS) is currently (May 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -46.99 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ANVS as of May 2024 is 7.09. This means that ANVS is currently overvalued and has a potential downside of -14.68% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ANVS as of May 2024 is 7.09. This means that ANVS is currently overvalued and has a potential downside of -14.68% (Sold with Premium).
Is ANVS a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: ANVS is performing better - Values below 0%: ANVS is underperforming
Compare ANVS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 19.67% | -24.33% | 19.74% | -66.66% |
| US NASDAQ 100 | QQQ | 19.35% | -26.35% | 21.07% | -73.50% |
| US Dow Jones Industrial 30 | DIA | 19.92% | -22.86% | 22.35% | -60.26% |
| German DAX 40 | DBXD | 21.55% | -22.55% | 19.97% | -52.73% |
| UK FTSE 100 | ISFU | 19.77% | -26.95% | 20.89% | -53.00% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 20.16% | -22.13% | 35.01% | -31.07% |
| Hongkong Hang Seng | HSI | 19.16% | -40.26% | 33.44% | -32.94% |
| Japan Nikkei 225 | EXX7 | 20.25% | -18.28% | 25.35% | -49.08% |
| India NIFTY 50 | INDA | 18.89% | -20.60% | 19.55% | -68.17% |
| Brasil Bovespa | EWZ | 21.40% | -20.69% | 40.89% | -51.06% |
ANVS Annovis Bio Inc vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 20.12% | -21.35% | 19.95% | -74.13% |
| Consumer Discretionary | XLY | 20.84% | -22.67% | 30.34% | -57.18% |
| Consumer Staples | XLP | 20.26% | -22.46% | 22.81% | -44.38% |
| Energy | XLE | 19.84% | -17.39% | 23.17% | -61.71% |
| Financial | XLF | 19.32% | -22.63% | 15.20% | -71.01% |
| Health Care | XLV | 19.32% | -22.70% | 22.82% | -51.60% |
| Industrial | XLI | 21.17% | -21.43% | 17.80% | -66.06% |
| Materials | XLB | 20.91% | -20.99% | 21.31% | -57.95% |
| Real Estate | XLRE | 19.07% | -25.43% | 28.33% | -49.21% |
| Technology | XLK | 18.74% | -27.42% | 22.47% | -73.95% |
| Utilities | XLU | 19.81% | -27.96% | 18.57% | -51.54% |
| Aerospace & Defense | XAR | 20.24% | -25.76% | 22.88% | -62.78% |
| Biotech | XBI | 19.86% | -27.48% | 13.04% | -45.18% |
| Homebuilder | XHB | 20.73% | -24.40% | 6.87% | -89.20% |
| Retail | XRT | 21.79% | -24.09% | 17.03% | -67.85% |
Does Annovis Bio Inc outperform its market, is ANVS a Sector Leader?
No, over the last 12 months Annovis Bio Inc (ANVS) made -38.35%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months ANVS made -17.40%, while XBI made -1.30%.
No, over the last 12 months Annovis Bio Inc (ANVS) made -38.35%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months ANVS made -17.40%, while XBI made -1.30%.
| Period | ANVS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -17.40% | 10.08% | 6.93% |
| 3 Months | -17.40% | -1.30% | 6.91% |
| 12 Months | -38.35% | 6.83% | 28.31% |